Diagnostics
Diagnostics Market Research, Intelligence and Forecasts
In this section you will find information products, including market research, regarding diagnostics market, including latest technologies, company profiles, biopharmaceuticals, market data and information covering Europe, the UK, North America and Asia.Stay up-to-date with new products added to this category »
| Title | Publication Date | Price |
|---|---|---|
|
Molecular Diagnostics Technologies, Markets and Companies |
March 2010 | £3300 |
|
The Future of The in-Vitro Diagnostics Market to 2016 Increasing Diagnostic Procedures Drive Demand |
January 2010 | £2310 |
|
Chinese Markets for In Vitro Diagnostics |
January 2010 | £2640 |
|
Molecular Diagnostics in Cancer Testing |
December 2009 | £2245 |
|
Point of Care Diagnostics |
December 2009 | £3205 |
|
Point of Care Diagnostics: Players, Products & Future Market Prospects |
November 2009 | £995 |
|
DNA Probes-Based Diagnostics A Worldwide Market Review |
November 2009 | £1980 |
|
Peptic Ulcer Testing A World Market Intelligence Report |
November 2009 | £1980 |
|
Genetic Testing A Global Update of Market Trends & Opportunities |
November 2009 | £1980 |
|
Molecular Diagnostics A World Market Review |
November 2009 | £1980 |
|
UK Diagnostic Imaging Market Analysis and Forecasts to 2015 |
September 2009 | £2310 |
|
Competitor Analysis VEGF and VEGF-R Agonists and Antagonists |
September 2009 | £540 |
|
Advanced Digital Diagnostic Medical Imaging Equipment Market Analysis & Directions |
September 2009 | £1515 |
|
U.S. DNA-Based Diagnostic Test and Equipment Market Analysis & Directions Market Trends, New Product Trends, Technology Trends, Distribution Structure and 15 Notable Company Case Studies |
September 2009 | £1850 |
|
Over-the-Counter Diagnostic Products World Markets |
August 2009 | £2245 |
|
Global Molecular Diagnostics Market Opportunities & Future Forecast |
August 2009 | £660 |
|
Infectious Disease Diagnostic Markets |
August 2009 | £2310 |
|
Coagulation Factors 2009 Target Pipeline and Corporate Benchmark Analysis |
August 2009 | £2195 |
|
Medical Ultrasound Systems Market Worldwide. 2009 |
July 2009 | £1650 |
|
Strategic Analysis of U.S. Drugs of Abuse Laboratory Testing |
July 2009 | £3965 |
|
The Top 40 Manufacturers Of Diagnostic Imaging Equipment In Europe |
June 2009 | £250 |
|
Point of Care Diagnostic Testing Sector Trends |
June 2009 | £2245 |
|
The Top 100 Point-Of-Care Manufacturing Companies Worldwide Second Edition |
May 2009 | £625 |
|
HIV Qualitative NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Viral Load NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Qualitative NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Genotyping NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Viral Load NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Viral Load NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Viral Load NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Viral Load NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Genotyping NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Genotyping NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Qualitative NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Qualitative NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Genotyping NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Genotyping NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Qualitative NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Viral Load NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HPV Genotyping NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HPV Genotyping NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HPV Genotyping NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HPV Genotyping NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HPV Genotyping NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HPV Quantitative NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HPV Quantitative NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HLA Typing NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HLA Typing NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Viral Load NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Viral Load NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Viral Load NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HLA Typing NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HLA Typing NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HLA Typing NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HIV Viral Load NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Genotyping NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Group B Streptococcus (GBS) NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Group B Streptococcus (GBS) NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Group A Streptococcus (GAS) NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Group A Streptococcus (GAS) NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Group B Streptococcus (GBS) NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Group B Streptococcus (GBS) NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Quantitative NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Quantitative NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Group B Streptococcus (GBS) NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Group A Streptococcus (GAS) NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Group A Streptococcus (GAS) NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Fragile X NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Factor V Leiden NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Factor V Leiden NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Factor V Leiden NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Fragile X NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Fragile X NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Group A Streptococcus (GAS) NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Fragile X NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Fragile X NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Quantitative NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Quantitative NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HPV Quantitative NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Genotyping NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Genotyping NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Genotyping NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Genotyping NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Qualitative NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Qualitative NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Qualitative NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Qualitative NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Viral Load NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Viral Load NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Ressistance NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Ressistance NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Ressistance NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Quantitative NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Ressistance NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Ressistance NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Viral Load NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Viral Load NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HBV Viral Load NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HCV Qualitative NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HSV 1 NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Parainfluenza 1, 2, 3 NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Parainfluenza 1, 2, 3 NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Parainfluenza 1, 2, 3 NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Neisseria Gonorrheae (NG) NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Parainfluenza 1, 2, 3 NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Parainfluenza 1, 2, 3 NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
RSV NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
RSV NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
RSV NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Neisseria Gonorrheae (NG) NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Neisseria Gonorrheae (NG) NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Mycobacterium tuberculosis (MTB) NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Mycobacterium tuberculosis (MTB) NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Mycobacterium Tuberculosis Direct (MTD) NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Mycobacterium Tuberculosis Direct (MTD) NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Mycobacterium tuberculosis (MTB) NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Mycobacterium tuberculosis (MTB) NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Neisseria Gonorrheae (NG) NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Neisseria Gonorrheae (NG) NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Mycobacterium tuberculosis (MTB) NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
RSV NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
RSV NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
VZV NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
VZV NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
VZV NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
VZV NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Warfarin sensitivity (CYP2C9, VKOR1) NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
VZV NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
VRE NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Staphylococcus aureus NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Staphylococcus aureus NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Staphylococcus aureus NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Staphylococcus aureus NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Staphylococcus aureus NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
VRE NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
VRE NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
VRE NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
VRE NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Mycobacterium Tuberculosis Direct (MTD) NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Mycobacterium Tuberculosis Direct (MTD) NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Her2Neu NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Her2Neu NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Her2Neu NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Her2Neu NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Her2Neu NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Human Metapneumovirus (hMPV) NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Human Metapneumovirus (hMPV) NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Human Metapneumovirus (hMPV) NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Human Metapneumovirus (hMPV) NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HSV 2 NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HSV 2 NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HSV 1 NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HSV 1 NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HSV 1 NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HPV Quantitative NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Factor V Leiden NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HSV 1 NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HSV 2 NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HSV 2 NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HSV 2 NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Human Metapneumovirus (hMPV) NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Influenca A/B NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MSSA NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MRSA NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MRSA NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MRSA NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MSSA NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MSSA NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Mycobacterium Tuberculosis Direct (MTD) NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MSSA NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MSSA NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MRSA NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MRSA NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Influenca A/B NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Influenca A/B NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Influenca A/B NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Influenca A/B NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MAC NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MAC NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MAC NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MAC NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
MAC NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
HPV Quantitative NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Epstein-Barr Virus (EBV) NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
CMF Viral Load NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
CMF Viral Load NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
CMF Viral Load NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
BK Virus NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
BK Virus NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
BK Virus NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
BK Virus NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
CMF Viral Load NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
CMF Viral Load NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Chlamydia Trachomatis (CT) NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Chlamydia Trachomatis (CT) NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
CMV Quant NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
CMV Quant NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
CMV Quant NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
CMV Quant NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
BK Virus NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Assessment of the Molecular Diagnostic Market for Adenovirus NA Tests in Germany |
April 2009 | £360 |
|
Technology Trends and Business Opportunities in Latin American X-Ray Market |
April 2009 | £3965 |
|
Adenovirus NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Diagnostics & Pathology in India |
April 2009 | £600 |
|
Medical Diagnostics - India |
April 2009 | £230 |
|
Diagnostic & Medical Laboratories in the US IBISWorld Industry Report |
April 2009 | £430 |
|
Factor V Leiden NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Adenovirus NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Adenovirus NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Assessment of the Molecular Diagnostic Market for 44 NA Tests in Spain |
April 2009 | £8065 |
|
Assessment of the Molecular Diagnostic Market for 44 NA Tests in UK |
April 2009 | £8065 |
|
Assessment of the Molecular Diagnostic Market for 44 NA Tests in Italy |
April 2009 | £8065 |
|
Assessment of the Molecular Diagnostic Market for 44 NA Tests in Germany |
April 2009 | £8065 |
|
Adenovirus NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Assessment of the Molecular Diagnostic Market for 44 NA Tests in France |
April 2009 | £8065 |
|
Chlamydia Trachomatis (CT) NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
CMV Quant NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Chlamydia Trachomatis (CT) NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Enterovirus NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Epstein-Barr Virus (EBV) NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Enterovirus NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Enterovirus NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Cystic Fibrosis, Mucoviscoidosis NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Enterovirus NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Epstein-Barr Virus (EBV) NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Epstein-Barr Virus (EBV) NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Factor II NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Factor II NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Factor II NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Factor II NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Epstein-Barr Virus (EBV) NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Factor II NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Cystic Fibrosis, Mucoviscoidosis NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Enterovirus NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Chlamydia Trachomatis (CT) NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Cystic Fibrosis, Mucoviscoidosis NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Clostridium Difficile (C.diff) NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Chlamydia trachomatis/Neisseria gonorrheae (CT/NG) NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Clostridium Difficile (C.diff) NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Cystic Fibrosis, Mucoviscoidosis NA Tests in Germany Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Clostridium Difficile (C.diff) NA Tests in UK Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Cystic Fibrosis, Mucoviscoidosis NA Tests in France Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Clostridium Difficile (C.diff) NA Tests in Italy Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
Clostridium Difficile (C.diff) NA Tests in Spain Assessment of the Molecular Diagnostic Market |
April 2009 | £360 |
|
In-Vitro Diagnostics US Industry Study with Forecasts for 2013 & 2018 |
March 2009 | £3170 |
|
InvestFrost Healthcare - European Ophthalmic Surgical Devices Market Outlook |
March 2009 | £3965 |
|
Top Ten Global In-Vitro Diagnostics Companies Positioning, performance and SWOT analyses |
March 2009 | £2025 |
|
The Top 100 Molecular Diagnostics Manufacturing Companies Worldwide |
March 2009 | £625 |
|
World Market for Molecular Diagnostics, The |
January 2009 | £2640 |
|
Molecular Diagnostics A Dynamic and Rapidly Broadening Market Overview |
January 2009 | £2475 |
|
Molecular Diagnostics: a primer on an emerging sector |
November 2008 | £2640 |
|
High-Growth Diagnostic Testing Markets |
November 2008 | £2245 |
|
HighGrowth Diagnostic Markets |
November 2008 | £2245 |
|
Molecular Diagnostics Markets |
September 2008 | £2245 |
|
Point of Care Diagnostic Testing World Markets |
September 2008 | £2245 |
|
Women's Health: Diagnostic Testing |
August 2008 | £1200 |
|
Commercializing Molecular Diagnostics: Products, Services, Companies and Global Market |
July 2008 | £1715 |
|
In Vitro Diagnostics Market Report & Analysis 2008-2023 |
June 2008 | £1499 |
|
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) |
June 2008 | £1980 |
|
B·R·A·H·M·S Aktiengesellschaft Product Pipeline Analysis |
May 2008 | £495 |
|
Genomics World Markets |
May 2008 | £2245 |
|
The Worldwide Market for In Vitro Diagnostic Tests 6th Edition [with 2009 Economy Preface] |
May 2008 | £2640 |
|
Epigenetics and MicroRNA Diagnostics/Therapeutics 2008 |
May 2008 | £2350 |
|
Multiplexed Diagnostics 2008 |
May 2008 | £2350 |
|
Convergence of Biomarkers and Diagnostics, The Therapy Area Analyses, Key Products and Future Trends |
April 2008 | £1995 |
|
Diagnostics & Pathology Laboratories |
April 2008 | £600 |
|
Blood Banking and Blood products |
March 2008 | £2610 |
|
Molecular Diagnostics in China |
February 2008 | £2640 |
|
Clinical Diagnostics in China Market Sector Analyses and Participant Directory |
January 2008 | £6865 |
|
U.S.DNA-Based Diagnostic and Test Market |
January 2008 | £1850 |
|
DNA Diagnostics: Technologies and Global Markets |
January 2008 | £3205 |
|
Cytogenetics, FISH and Molecular Testing in Hematologic Malignancies |
January 2008 | £110 |
|
The Decentralized Diagnostic Testing Markets Business Challenges And Marketing Strategies |
January 2008 | £13075 |
|
Three Alternative Scenarios Of The Future In Vitro Diagnostics Market 2007-2016 |
January 2008 | £7795 |
|
Nanotechnology Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics |
January 2008 | £1995 |
|
In Vitro Diagnostics Development through Postmarket |
January 2008 | £2175 |
|
The World Orthopaedic Market Report 2008 |
December 2007 | £995 |
|
Diagnosis of Fungal Infections |
December 2007 | £115 |
|
Textbook of Men's Health and Aging |
December 2007 | £0 |
|
The Endometrium: Molecular, Cellular and Clinical Perspectives 2nd edition |
December 2007 | £280 |
|
Encephalitis: Diagnosis and Treatment |
December 2007 | £115 |
|
Diagnostic Ultrasound |
November 2007 | £315 |
|
Cell-Based Diagnostics: Technology, Applications, and Markets 2nd Edition |
November 2007 | £2640 |
|
Mayo Clinic Cardiology: Board Review Questions and Answers |
November 2007 | £115 |
|
Clinical Diagnosis and Management of Dystonia |
November 2007 | £75 |
|
Dispense & Imaging Trends 2007 |
November 2007 | £1540 |
|
Myeloproliferative Disorders: Biology and Management |
October 2007 | £105 |
|
Medical Imaging Equipment And Related Products |
October 2007 | £3205 |
|
Anaerobic Infections: Diagnosis and Management |
September 2007 | £115 |
|
Physiological Basis of Aging and Geriatrics 4th edition |
September 2007 | £85 |
|
Functional Neuroradiology |
September 2007 | £145 |
|
Advances in Nuclear Oncology: Diagnosis and Therapy |
September 2007 | £215 |
|
Clinical Handbook of Pediatric Infectious Disease |
September 2007 | £95 |
|
Mayo Clinic Internal Medicine Concise Textbook |
September 2007 | £55 |
|
Handbook of Sleep Disorders, 2nd |
September 2007 | £145 |
|
Market Status and Forecast on Chinese Diagnostic Imaging Equipment Market |
August 2007 | £230 |
|
Atlas of Cardiometabolic Risk |
August 2007 | £55 |
|
Garner and Klintworth's Pathobiology of Ocular Disease, 3rd edition |
August 2007 | £0 |
|
Clinical Diagnosis and Management of Dystonia |
August 2007 | £75 |
|
Dermal Absorption and Toxicity Assessment |
August 2007 | £130 |
|
Diagnosis of Fungal Infections |
August 2007 | £115 |
|
Managing Antimicrobial Resistance |
August 2007 | £115 |
|
Pediatric Retina |
August 2007 | £145 |
|
The Diagnostic Equipment Service Conundrum How Much Is Too Much? How Little Is Too Little? |
July 2007 | £1320 |
|
Head and Neck Manifestations of Systemic Disease |
July 2007 | £170 |
|
China's In Vitro Diagnostic Testing Industry Sector Snapshot |
June 2007 | £330 |
|
Early Toxicology Markets and Approaches |
June 2007 | £2310 |
|
Advances in Nuclear Oncology Diagnosis and Therapy |
June 2007 | £140 |
|
Valvular Heart Disease Pathologic, Echocardiographic and Surgical Correlations |
June 2007 | £135 |
|
Fractures of the Pelvis and Acetabulum |
June 2007 | £110 |
|
Myocardial Perfusion Scintigraphy: From Request to Report |
June 2007 | £125 |
|
Myocardial Perfusion Scintigraphy: From Request to Report |
June 2007 | £105 |
|
The Aorta: Structure, Function, Dysfunction and Diseases |
June 2007 | £125 |
|
Antimicrobial Pharmacodynamics in Theory and Clinical Practice, 2nd Edition |
June 2007 | £110 |
|
Molecular Diagnostics 2007 Technologies, Companies, Products, Applications and Worldwide Outlook |
May 2007 | £1515 |
|
Atlas of Intracytoplasmic Sperm Injection |
May 2007 | £75 |
|
Neurogenetics of Psychiatric Disorders |
May 2007 | £100 |
|
Obstructive Sleep Apnea Diagnosis and Treatment |
May 2007 | £145 |
|
Chronic Rhinosinusitis |
May 2007 | £110 |
|
Physician Office Laboratory (POL) Testing Markets Worldwide Status Quo and Future Trends |
May 2007 | £2310 |
|
In Vitro Diagnostics to 2009 Demand and Sales Forecasts, Market Share, Market Size, Market Leaders |
April 2007 | £2970 |
|
The Vulnerable Plaque, 2nd edition |
April 2007 | £210 |
|
Fever of Unknown Origin |
April 2007 | £130 |
|
Problem-Oriented Approaches in Interventional Cardiology |
April 2007 | £115 |
|
Rickettsial Diseases |
April 2007 | £130 |
|
Medical Immunology, 6th edition |
April 2007 | £74.99 |
|
Echocardiography: A Practical Guide for Reporting 2nd edition |
April 2007 | £50 |
|
Heparin-Induced Thrombocytopenia 4th edition |
April 2007 | £115 |
|
Twin-Twin Transfusion Syndrome |
April 2007 | £85 |
|
The Market for In Vitro Toxicology Testing |
March 2007 | £3205 |
|
Therapeutic/Diagnostic Devices for Neurological Disorders |
March 2007 | £3205 |
|
Molecular Diagnostics Major World Markets |
February 2007 | £2640 |
|
Lateral Flow Technology and the Future of Point of Care Diagnostics |
February 2007 | £1980 |
|
Medical and Diagnostic Laboratories in the US IBISWorld Industry Report |
January 2007 | £430 |
|
Complete Guide to the Diagnostic Market 2007-2012 |
January 2007 | £1600 |
|
In Vitro Diagnostic Industry Leading Players Comparison and Review Sector Snapshot |
January 2007 | £330 |
|
Clinical Diagnostics in India Market Sector Analyses and Participant Directory |
December 2006 | £3300 |
|
Medical Imaging: Reagents and Analysis Tools |
December 2006 | £2885 |
|
Worldwide Point of Care (POC) Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver? |
November 2006 | £1980 |
|
Innovations in Diagnostics |
September 2006 | £1495 |
|
Blood The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products |
September 2006 | £2575 |
|
Point of Care Diagnostics Market in the US: |
August 2006 | £1870 |
|
India's In Vitro Diagnostic Testing Industry Sector Snapshot |
July 2006 | £330 |
|
Patient Monitoring |
April 2006 | £2885 |
|
Diagnostics and Therapeutics for Genetic Diseases |
April 2006 | £2885 |
|
Market Opportunity Analysis for Point of Care Diagnostic Testing in France, A |
March 2005 | £2750 |
|
The Top 100 In Vitro Diagnostics Manufacturing Companies In Europe (2nd ed.) |
April 2004 | £625 |
|
Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players) |
April 2004 | £2310 |
|
World Markets for Point of Care Diagnostics 2009-13 |
April 2004 | £2180 |
|
Who's Doing What in Molecular Diagnostics? Kalorama / Emmes Survey of US Laboratories |
February 2002 | £3300 |
